When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...

Cardinal Health (NYSE:CAH) has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price ...

A mighty gust of wind on a dreary morning only lifted the sail of the freshly cut ribbon, on Community Action House’s new set ...

Aroostook County residents received a major boost this tax season thanks to the Aroostook CA$H Coalition, which once again ...

A physician survey for Neurocrine Biosciences Inc's NBIX +1.72% Get Free Report Crenessity suggests "strong uptake across all patient segments," according to Needham. The Neurocrine Biosciences ...

Our other programs will be discussed at a later time. Historically, Spruce's efforts have been primarily directed towards the development of Tralesinidase for CAH. And although we executed the program ...

In a report released today, Allen Lutz from Bank of America Securities maintained a Buy rating on Cardinal Health (CAH – Research Report). The ...

Cardinal Health Inc. closed 5.54% short of its 52-week high of $139.50, which the company achieved on April 3rd.

Many hospitals in Maine, particularly larger ones, are heavily in debt, poor and working out of older facilities, according ...

The stock's rise snapped a four-day losing streak.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...